Following proteomic analysis of pooled control, MCI and AD plasma, normalised total spectral counts using Scaffold software and emPAI values from Mascot showed complement component 2, fibronectin and fibrinogen to be significantly increased in the AD groups compared to the control group (Table 3). Here, C2 is linked to Alzheimer disease.